Ogkologos

3694 POSTS 0 COMMENTS

Sacituzumab Govitecan Demonstrates a Relatively High ORR with Rapid Responses in...

Ogkologos - September 16, 2024

Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers

Ogkologos - September 14, 2024

Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group...

Ogkologos - September 13, 2024

From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing,...

Ogkologos - September 13, 2024

ESMO 2024 Press Conference

Ogkologos - September 13, 2024

FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for...

Ogkologos - September 12, 2024

Study Identifies Hundreds of Potential Targets for Cancer Drugs

Ogkologos - September 11, 2024

Six Years of Adjuvant Imatinib Improves DFS Over Three Years Treatment...

Ogkologos - September 11, 2024

ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being...

Ogkologos - September 10, 2024

FDA Approves Lazertinib with Amivantamab-vmjw for Locally Advanced or Metastatic NSCLC...

Ogkologos - September 9, 2024

12 3...370 Page 1 of 370

MOST POPULAR

Researchers Discover Genetic Marker That Increases Risk Of Premenopausal Breast Cancer

August 2, 2019

EMA Recommends Extension of Therapeutic Indications for Osimertinib

April 26, 2021

DIY Mosquito Traps & Deterrents (That Really Work)

June 23, 2021

Cannabis, cannabinoids and cancer – the evidence so far

September 1, 2021

Sacituzumab Govitecan Demonstrates a Relatively High ORR with Rapid Responses in...

Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers

Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group...

From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing,...

ESMO 2024 Press Conference

FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for...

Study Identifies Hundreds of Potential Targets for Cancer Drugs

Six Years of Adjuvant Imatinib Improves DFS Over Three Years Treatment...

ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being...

FDA Approves Lazertinib with Amivantamab-vmjw for Locally Advanced or Metastatic NSCLC...

MOST POPULAR

Researchers Discover Genetic Marker That Increases Risk Of Premenopausal Breast Cancer

EMA Recommends Extension of Therapeutic Indications for Osimertinib

DIY Mosquito Traps & Deterrents (That Really Work)

Cannabis, cannabinoids and cancer – the evidence so far

HOT NEWS

Mapping Cancer Genomic Evolution Offers Insights into Tumor Development

FDA Approves Pralsetinib for RET-Altered Thyroid Cancers

Study Advances Fertility Preservation Approach for Male Cancer Survivors

Prescribing Exercise as Cancer Treatment: A Conversation with Dr. Kathryn Schmitz

Follow us on Instagram @ogkologos

POPULAR POSTS

Comme louer son affaire en compagnie de tacht mahometane? (2023)

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

Stopping neuropathy: One of chemotherapy’s most challenging side effects

POPULAR CATEGORY